{
  "id": 17985157,
  "title": "Funders Float ‘Natural Selection’ for Non-Profit Neglected Disease Drug Developers as Global Health Aid Dries Up",
  "url": "https://urgent.news/2026/11/03/funders-float-natural-selection-for-non-profit-neglected-disease-drug",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-03T15:15:58.000Z",
  "source": {
    "name": "Health Policy Watch",
    "slug": "health-policy-watch",
    "url": "https://healthpolicy-watch.news/funders-float-natural-selection-for-non-profit-neglected-disease-drug-developers-as-global-health-aid-dries-up/"
  },
  "original_language": "en",
  "account": null,
  "summary": "In the late 1990s, doctors treating sleeping sickness, a parasitic disease spread by tsetse flies that is almost always fatal without treatment, still relied on melarsoprol, an arsenic-based drug that killed roughly one patient in 20. One patient given melarsoprol in 2003 later recalled the injection “felt like fire” being injected into his veins, turning […]",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}